Size: 2 mg / 5 mg
Modified GRF 1-29 replicates physiological GHRH stimulation. Lacking the Drug Affinity Complex (DAC), it preserves natural pulsatile GH release patterns without causing continuous endocrine elevation.
Supply duration: 8 to 12 weeks continuous administration
Binds GHRH receptors on anterior pituitary somatotrophs, activating adenylate cyclase and driving pulsatile growth hormone secretion. Four amino acid substitutions protect against rapid dipeptidyl peptidase-IV (DPP-IV) cleavage, extending its elimination half-life to ~30 minutes.
PURITY CHECK
HPLC Chromatogram provided with every shipment.
ZERO FILLERS
Free of residual solvents, heavy metals, or unlisted buffers.
SECURE DELIVERY
Discreet, protective thermal packaging.
DAC extends the half-life to ~7 days for continuous GH elevation, whereas "no DAC" has a 30-minute half-life that preserves natural pulsatile GH spikes.
You can feel it in your focus, your recovery, and your daily rhythm.
Three simple steps for a desired outcome
Proper storage and handling of laboratory reagents in vial format is crucial for ensuring their effectiveness and reliability. To maintain their integrity, it's important to follow specific guidelines for temperature control, light exposure, and contamination prevention.
